Preexposure Prophylaxis for the Prevention of HIV Infection
Top Cited Papers
Open Access
- 11 June 2019
- journal article
- review article
- Published by American Medical Association (AMA) in Jama-Journal Of The American Medical Association
- Vol. 321 (22), 2203-2213
- https://doi.org/10.1001/jama.2019.6390
Abstract
The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms.Keywords
This publication has 60 references indexed in Scilit:
- Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical TrialPLOS ONE, 2013
- Preexposure Prophylaxis for HIV Infection among African WomenNew England Journal of Medicine, 2012
- Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex WorkersPLOS ONE, 2012
- Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couplesAIDS, 2011
- Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San FranciscoPLOS ONE, 2011
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenNew England Journal of Medicine, 2010
- Chemoprophylaxis for HIV Prevention: New Opportunities and New QuestionsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Prediction of HIV Acquisition Among Men Who Have Sex With MenSexually Transmitted Diseases, 2009
- Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and TenofovirPLoS Medicine, 2008
- Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2, Double-Blind, Randomized, Placebo-Controlled TrialPLoS Clinical Trials, 2007